Modified AAV Capsid for Inner Ear Hair Cell Infection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current inner ear gene therapy methods face low infection efficiency in hair cells and supporting cells, limiting their effectiveness in treating hearing loss and dizziness.
Innovation Solution
A recombinant adeno-associated virus (AAV) virion with a modified capsid protein containing a peptide insertion (LGETTRP) is used to enhance infection efficiency in inner ear hair cells, delivering genetic material to reduce hearing loss and dizziness by targeting specific genes associated with these conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional AAV vectors are used for inner ear gene therapy, then the therapy can be administered, but the infection efficiency in hair cells and supporting cells remains low
Solution Approach 1:
The patent applies parameter changes by modifying the amino acid sequence of the AAV capsid protein. Specifically, amino acid residues at positions 587-588 of the VP1 capsid protein are mutated (e.g., to LGETTRP sequence), which changes the physical-chemical properties of the capsid surface. This parameter modification enables the viral vector to efficiently infect inner ear hair cells and supporting cells that were previously resistant to conventional AAV vectors.
2Reliability
If the AAV capsid protein is modified to improve hair cell infection, then infection efficiency increases, but the complexity of vector design and manufacturing increases
Solution Approach 1:
The patent applies local quality by making targeted, localized modifications to specific regions of the AAV capsid protein rather than redesigning the entire vector. The mutation is confined to a specific epitope region (amino acids 587-588 of VP1), allowing the rest of the capsid structure to remain intact and functional. This localized approach improves hair cell infection while minimizing the complexity increase compared to comprehensive vector redesign.
Data Source
AI summary
Provided herein are adeno-associated viruses and methods for using same to treat or prevent disorders that affect the inner ear of a subject.


